Díaz de LPM, Moreno SAA, González DJI, Briones GJC

Language: Spanish
References: 16
Page: 217-222
PDF size: 188.76 Kb.

ABSTRACT

ARDS was first described in 1967 and was characterized as dyspnea, hypoxemia and bilateral infiltrates in the thorax radiography. Initially the «A» in ARDS meant «adult» and it was used to differentiate this syndrome from the infantile form. Since 1994 the «A» stands for «acute», because ARDS occurs in all ages.
We define ARDS as the presence of non-cardiogenic pulmonary edema and respiratory failure, characterized by increased permeability of the aveolar-capillary membrane, diffuse alveolar damage, and the accumulation of proteinaceous pulmonary edema.
Is one of the main causes of mortality in the Intensive Care Units.
There are no specific treatment that correct the pulmonary damage, however the use of appropriate strategies of mechanical ventilation and pharmacological therapies have led to a more favorable outcome.

REFERENCES

1. Díaz De León PM, Mujica HM, Olvera CA, González DJ, Montealegre RPA, Moreno SAA, González GN. Síndrome de insuficiencia respiratoria aguda (SIRA). Rev Asoc Mex Med Crit y Ter Int 2004;18(1):24-33.

2. Ware LB, Matthay MA. The acute respiratory distress syndrome. NEJM 2000;342:1334-1349.

3. Duncan LA, Timothy WE. Acute respiratory distress syndrome. Lancet 1999;354: 497-501.

4. Stephen Derdak, D. Acute respiratory distress syndrome in trauma patients. J Trauma 2007;62:S58.

5. Craig J, Gordon DR. Effect of age on the development of ARDS in trauma patients. Chest 2003; 124:653-659.

6. Bernard GR, Artigas A, Brigham KL. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824.

7. Derdak S. Acute respiratory distress syndrome in trauma patients. J Trauma 2007;62(6 Suppl):S58.

8. Morty RE, Eickelberg O, Seeger W. Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies? Intensive Care Med 2007;33(7):1229-40.

9. Brower RG, Ware LB. Treatment of ARDS. Chest 2001;120(4):1347-1367.

10. Agarwal R, Nath A, Aggarwal AN, Gupta D. Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis. Respirology 2007;12(4):585-90.

11. Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest 2007;131:913-920.

12. Meduri UG, Golden E. Methylprednisolone infusion in early severe ARDS. Chest 2007;131:954-963.

13. Petrucci N, Iacovelli W. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2007;18(3):112-118.

14. Marini JJ. Lung protection in acute respiratory distress syndrome: the neglected vascular side. Crit Care Med 2007;35(7):1796-7.

15. Laffey JG, Kavanagh BP, Ney L, Kuebler W. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. NEJM 2000;342:1301-1308.

16. Carrillo ER, Cruz-Suárez MA. Ventilación líquida en el síndrome de insuficiencia respiratoria aguda. Rev Fac Med UNAM 2002; 45(5): 225-228.